Androgenetic Alopecia vs Alopecia Areata: Two Types of Hair Loss That Couldn't Be More Different

You’re losing hair. The instinct is to assume it’s male pattern baldness - after all, it affects roughly half of men by middle age. But not all hair loss plays by the same rules. Androgenetic alopecia and alopecia areata share a symptom (hair falling out) and almost nothing else. One is driven by hormones and genetics. The other is your immune system attacking your own follicles. Getting the diagnosis wrong means getting the treatment wrong, so understanding the distinction matters.

Quick Comparison

What Is Androgenetic Alopecia?

Androgenetic alopecia (AGA) is the classic “male pattern baldness” - the receding hairline, thinning crown, and eventual horseshoe pattern that most men recognize. It’s overwhelmingly genetic. Twin studies put heritability at around 79%, and some estimates run as high as 98-99% [1][2]. Prevalence tracks neatly with age: roughly 20% of men in their twenties, 30% in their thirties, and so on up through each decade [1].

The engine behind AGA is dihydrotestosterone (DHT), a potent androgen converted from testosterone by the enzyme 5-alpha reductase. DHT binds to androgen receptors in genetically susceptible scalp follicles and triggers a cascade of events: shortened growth cycles, follicle miniaturization, increased TGF-beta1 secretion, and eventually fibrosis that chokes off the follicle entirely [5][6][7]. The key word is “susceptible” - follicles on the sides and back of the head largely resist this process, which is why those areas are used as donor sites for hair transplants.

Testosterone itself also contributes. Men on dutasteride who crush their DHT to near-zero levels can still experience shedding, because testosterone alone can bind androgen receptors and drive miniaturization [8]. This is why AGA is sometimes called “androgen-dependent” rather than purely “DHT-dependent.” Lifestyle factors play a modifying role too - smoking and elevated BMI are both associated with more severe hair loss [9][10] - but they operate on top of a genetic foundation, not instead of it.

What Is Alopecia Areata?

Alopecia areata (AA) is fundamentally different. It’s an autoimmune condition in which T-cells target hair follicles, collapsing the immune privilege that normally protects them. The result is sudden, patchy hair loss - smooth, round bald spots that appear over days rather than years [11][12].

The clinical spectrum ranges from a single small patch (alopecia unilocularis) to multiple patches (alopecia multilocularis) to complete scalp hair loss (alopecia totalis) or total body hair loss (alopecia universalis). Unlike AGA’s predictable march from hairline to crown, AA can strike anywhere on the scalp - or the beard, eyebrows, and body hair [13].

Stress appears to be a meaningful trigger. In one retrospective cohort, 58.6% of late-onset AA patients reported a significant stressful event preceding their hair loss [3]. Chronic stress can provoke autoimmune flare-ups that manifest as discrete patches rather than the diffuse thinning characteristic of AGA [11]. Gut health also plays a role - emerging research links gut dysbiosis to AA pathogenesis, and elimination diets that address intestinal permeability have shown anecdotal promise [14][15].

The good news: AA follicles are attacked but not destroyed. The stem cells in the bulge region survive, which is why spontaneous regrowth happens frequently. In that same late-onset cohort, 82.8% of patients achieved complete hair regrowth, though 37.9% later relapsed [3]. This stands in stark contrast to AGA, where miniaturized follicles rarely recover even when androgens are removed [4].

Key Differences Between Androgenetic Alopecia and Alopecia Areata

The Pattern Tells the Story

The single most reliable clinical distinction is the pattern of loss. AGA follows the Norwood-Hamilton classification: recession at the temples, thinning at the vertex, gradual merging. It’s bilateral, symmetric, and predictable. AA produces circular or oval patches with sharp borders and no respect for the typical male pattern. A dermatologist can usually differentiate them on sight, and dermoscopy makes it even clearer - AGA shows miniaturized vellus hairs mixed with terminal hairs, while AA shows “exclamation point” hairs (short, broken hairs that taper at the base) and black dots [16].

Hormonal vs. Immune Pathology

AGA is a hormonal condition. It requires androgens - men castrated before puberty never develop it, and women with PCOS often experience it due to elevated testosterone [17]. The molecular pathway runs through androgen receptor binding, 5-alpha reductase activity, and downstream mediators like TGF-beta1 and reactive oxygen species [7].

AA is driven by interferon-gamma and other Th1 cytokines. Serum IFN-gamma is significantly elevated in AA patients, particularly those with totalis and universalis forms [13]. The condition clusters with other autoimmune diseases: thyroid disorders are present in up to 31% of AA patients [3], and vitamin D deficiency - a known risk factor for autoimmune conditions - is dramatically more prevalent, with one meta-analysis finding AA patients had 3.89 times higher odds of vitamin D deficiency compared to controls [18].

Treatment Philosophies Are Opposite

Treating AGA means blocking androgens or stimulating growth despite them. The core arsenal: finasteride (blocks type 2 5-alpha reductase, reducing scalp DHT), minoxidil (a vasodilator that stimulates follicle activity regardless of androgens), ketoconazole shampoo (anti-fungal with mild anti-androgen properties), and low-level laser therapy [19][20]. These treatments slow or halt progression but rarely produce dramatic regrowth. Finasteride blocks about 90% of progression over five years at 1 mg/day [1].

Treating AA means calming the immune system. First-line therapy is typically corticosteroids - topical, intralesional, or systemic depending on severity [21]. For resistant cases, contact immunotherapy with diphenylcyclopropenone (DPCP) has shown efficacy, and the newer JAK inhibitors (baricitinib, ritlecitinib) represent a genuine breakthrough, though they cost $20,000-$30,000 per year and require ongoing use [22]. Vitamin D supplementation is worth considering given the strong association between deficiency and disease severity - serum 25(OH)D levels inversely correlate with AA severity, and topical calcipotriol (a vitamin D analogue) achieved hair regrowth in 69.2% of mild-to-moderate patients in a 12-week trial [23][24].

Prognosis and Trajectory

AGA is progressive and permanent without intervention. Once a follicle undergoes terminal miniaturization and fibrosis sets in, it’s gone [5]. This is why early treatment matters - you’re preserving what you have, not regrowing what you’ve lost.

AA is unpredictable but often self-limiting. Many patients regrow hair spontaneously within a year, though relapse rates hover around 30-40% [3]. The uncertainty cuts both ways: some people recover fully and never relapse, while others progress to totalis or universalis despite treatment.

Androgenetic Alopecia vs Alopecia Areata: How to Know Which You Have

If your hair loss is gradual, follows the classic receding-hairline-plus-thinning-crown pattern, and your father or maternal grandfather had similar hair: you’re almost certainly dealing with androgenetic alopecia. A simple shower test can provide additional confirmation - fewer than 100 shed hairs per day with less than 10% shorter than 3 cm points toward AGA [25].

If you woke up with a smooth, round bald patch that appeared within days - especially after a period of significant stress: alopecia areata is the likely culprit. Multiple patches, involvement of the beard or eyebrows, and a history of other autoimmune conditions (thyroid disease, vitiligo, atopic dermatitis) all strengthen the case [3][11].

If you’re a woman experiencing diffuse thinning: the picture is murkier. Female-pattern AGA exists and is more common than most women realize (up to 57% of women by age 80), but it presents differently - diffuse thinning across the crown with preservation of the frontal hairline [20]. AA in women can also present diffusely. See a dermatologist who can use trichoscopy to distinguish miniaturized hairs (AGA) from exclamation-point hairs (AA).

If you’re on testosterone replacement therapy or anabolic steroids and losing hair: that’s almost certainly AGA acceleration. Exogenous androgens don’t cause alopecia areata - they accelerate the genetic hair loss you were already predisposed to [4][26].

For anyone with AA: get your vitamin D levels checked. The data is remarkably consistent - 91% of AA patients in one study were vitamin D deficient compared to 33% of healthy controls [24]. Consider addressing gut health through diet modification, as the gut-immune axis appears to play a genuine role in AA pathogenesis [14][15]. And know that corticosteroids and JAK inhibitors exist as real treatment options if spontaneous regrowth doesn’t occur.

For anyone with AGA: start treatment early. Finasteride, minoxidil, and ketoconazole form the evidence-based foundation [19][20]. Low-level laser therapy adds modest benefit as an adjunct [27]. And quit smoking if you haven’t already - the combination of smoking and elevated BMI increases your risk of moderate-to-severe AGA nearly sixfold [9].

References

1. Peter Attia - Male Pattern Hair-Loss Pathophysiology (https://www.youtube.com/watch?v=M5B8tNCXEy4)
2. Nutritionfacts - Genetic and Environmental Factors in Hair Loss (https://www.youtube.com/watch?v=vB8gT1QoeUY)
3. PubMed - Late-Onset Alopecia Areata: A Retrospective Cohort Study (https://pubmed.ncbi.nlm.nih.gov/29212074/)
4. MPMD - Androgenic Alopecia After Testosterone Use (https://www.youtube.com/watch?v=rt2nMq4KRdg)
5. Ryan Russo - Androgenic Alopecia Mechanism (https://www.youtube.com/watch?v=xZ3Sr2U90Cc)
6. PubMed - Induction of TGF-beta 1 by androgen is mediated by reactive oxygen species in hair follicle dermal papilla cells (https://pubmed.ncbi.nlm.nih.gov/24064061/)
7. PubMed - Androgen actions on the human hair follicle: perspectives (https://pubmed.ncbi.nlm.nih.gov/23016593/)
8. MPMD - Testosterone-not just DHT-drives androgenic alopecia (https://www.youtube.com/watch?v=orgtK_ByHYA)
9. PubMed - The combination of overweight and smoking increases the severity of androgenetic alopecia (https://pubmed.ncbi.nlm.nih.gov/28555720/)
10. PubMed - Association of androgenetic alopecia with smoking and its prevalence among Asian men (https://pubmed.ncbi.nlm.nih.gov/18025364/)
11. MPMD - Alopecia Areata vs. Androgenic Alopecia (https://www.youtube.com/watch?v=uGD6j8cGsqU)
12. MPMD - Comparing Alopecia Areata and Androgenic Alopecia (https://www.youtube.com/watch?v=qdRN6yeM8yY)
13. PubMed - Serum concentrations of interferon-gamma in patients with alopecia areata (https://pubmed.ncbi.nlm.nih.gov/21246917/)
14. MPMD - Understanding Alopecia Areata and Autoimmune Hair Loss (https://www.youtube.com/watch?v=qdRN6yeM8yY)
15. PubMed - The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies (https://pubmed.ncbi.nlm.nih.gov/36185693/)
16. MPMD - Distinguishing Androgenic Alopecia from Telogen Effluvium (https://www.youtube.com/watch?v=J2jPG58E1Bk)
17. Diet Doctor - Dr Jason Fung: Hyperandrogenism - PCOS 3 (https://www.dietdoctor.com/hyperandrogenism-women-with-high-levels-of-male-sex-hormones)
18. PubMed - Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta-analysis (https://pubmed.ncbi.nlm.nih.gov/29633370/)
19. MPMD - Big Four Hair-Loss Treatments Overview (https://www.youtube.com/watch?v=jHRuuRXi07s)
20. PubMed - Minoxidil in the treatment of androgenetic alopecia (https://pubmed.ncbi.nlm.nih.gov/30155952/)
21. PubMed - Alopecia areata: an evidence-based treatment update (https://pubmed.ncbi.nlm.nih.gov/25000998/)
22. Women’s Health Mag - This Autoimmune Disease Has Ravaged Women For Centuries (https://www.womenshealthmag.com/health/a64906863/alopecia-revolutionary-medications/)
23. PubMed - Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata (https://pubmed.ncbi.nlm.nih.gov/26091388/)
24. PubMed - Vitamin D deficiency in alopecia areata (https://pubmed.ncbi.nlm.nih.gov/24655364/)
25. MPMD - Hair-Shedding Test to Spot Early Androgenic Alopecia (https://www.youtube.com/watch?v=X1Y705rqcDE)
26. PubMed - Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia (https://pubmed.ncbi.nlm.nih.gov/15992088/)
27. PubMed - Systematic review of low-level laser therapy for adult androgenic alopecia (https://pubmed.ncbi.nlm.nih.gov/29286826/)